Clinical Trial Update: Temocillin vs Meropenem for the Targeted Treatment of Bacteraemia Resistant to Third Gen Cephalosporins [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing temocillin with meropenem for the targeted treatment of bacteremia caused by organisms resistant to third-generation cephal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia

Drugs mentioned

• Meropenem (Meropenem)
• Temocillin (temocillin)

Snippet

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Conditions: Bacteremia | Phase 3 | Status: COMPLETED